Discontinuation of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy: clinical implications in patients on CD4 T-cell-guided treatment interruption.
Lanzafame
Massimiliano
M
Lattuada
Emanuela
E
Gottardi
Martina
M
Antolini
Dario
D
Concia
Ercole
E
Vento
Sandro
S
D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods; D018791:CD4 Lymphocyte Count; D024921:Drug Resistance, Multiple, Viral / Q000235:genetics; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D009154:Mutation; D012367:RNA, Viral / Q000097:blood; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D028761:Withholding Treatment
D012367:RNA, Viral; D018894:Reverse Transcriptase Inhibitors